Medicare Price Negotiation Round Two: New Administration, More Drugs, Less Time

 
• By Cathy Kelly
  
Manufacturers targeted by the price negotiation process have little time to decide whether to participate. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Geography